Press release
Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends
Neoantigen Targeted Therapies Market Share
The neoantigen targeted therapies market has been growing significantly and is projected to continue this trend.
•2024 Market Size: $3.4 billion
•2025 Market Size: $4.72 billion (38.7% CAGR)
•2029 Market Size: $16.01 billion (35.7% CAGR)
These developments owe much to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, molecular profiling advancements among others.
What Is Driving The Growth In The Neoantigen Targeted Therapies Market?
The striking rise in cancer cases worldwide is a major catalyst propelling the growth of the neoantigen targeted therapies market. The incidence of cancer refers to the number of new cancer cases reported within a certain period in a specific population. Neoantigen-targeted therapies are often combined with other treatments to tackle different cancer types. Records from the American Cancer Society shows that in 2022, there were about 1.9 million new cancer cases in the United States, a considerably higher figure compared to previous years. More so, it was estimated that 609,360 deaths in the US were as a result of cancer. Thus, the escalating incidence of cancer cases is indeed a primary driver for the neoantigen targeted therapies market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
Who Are the Key Players Driving Neoantigen Targeted Therapies Market Growth?
•F. Hoffmann-La Roche AG
•Merck and Co. Inc.
•Bristol Myers Squibb Company
•Eli Lilly and Company
•Kite Pharma Inc., Gilead Sciences Inc.
•Amgen Inc.
•Moderna Inc.
•BioNTech SE
•Bavarian Nordic Inc.
•Advaxis Inc.
•Immatics NV
•Precision Biologics Inc.
•Iovance Biotherapeutics Inc.
•Agenus Inc.
•Achilles Therapeutics Plc
•Medigene AG
•Gritstone Bio Inc.
•SQZ Biotechnologies Company
•Aduro BioTech Inc.
•Inovio Pharmaceuticals Inc.
•Gradalis Inc.
•EpiVax Inc.
•ISA Pharmaceuticals BV
•Vaxon Biotech SA
•Ziopharm Oncology
•Genocea Biosciences Inc.
•Cellular Biomedicine Group Inc.
•Immunovaccine Inc.
What Are The Key Trends In The Neoantigen Targeted Therapies Market?
•Neoantigen resistance management
•Neoantigen-primed adoptive cell therapies
•Neoantigen-based combinatorial therapies
•Integration of real-world data
•Enhanced predictive models
What Are The Segments Of The Global Neoantigen Targeted Therapies Market?
•Type: Monotherapy, Combination Therapy
•Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
•Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
•Route Of Administration: Intradermal, Intravenous, Subcutaneous
•Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Which Region Leads The Neoantigen Targeted Therapies Market?
North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
What Is Covered In The Neoantigen Targeted Therapies Market Global Market Report?
- Market Size Analysis: Analyze the Neoantigen Targeted Therapies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neoantigen Targeted Therapies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neoantigen Targeted Therapies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neoantigen Targeted Therapies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11944&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends here
News-ID: 3834360 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neoantigen
Neoantigen Targeted Therapies Market Trends, Innovations, and Forecast Analysis
Neoantigen targeted therapies are a revolutionary class of immunotherapies that aim to stimulate the body's immune system to recognize and attack cancer cells. Neoantigens are tumor-specific antigens that arise from mutations in the DNA of cancer cells. These mutations produce abnormal proteins that are not present in normal cells, making them ideal targets for immune system recognition. Neoantigen-based therapies focus on developing personalized treatments by targeting these unique antigens, making…
Neoantigen Cancer Vaccine Market Size, Share & CAGR 69.43% to 2034
What is driving the explosive growth of the neoantigen cancer vaccine market?
The neoantigen cancer vaccine market is seeing one of the most rapid growth trajectories in modern oncology. With a market size of USD 116.74 million in 2024, it is projected to reach USD 22,757.41 million by 2034, growing at a CAGR of 69.43%. This unprecedented growth is being fueled by advancements in genomic technologies, the success of mRNA platforms…
Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Neoantigen Targeted Therapies Industry Market Size Be by 2025?
There has been a notable expansion in the market size of neoantigen targeted therapies in the last few years. This market is projected to grow from $3.4 billion in 2024 to $4.72 billion in 2025, experiencing a…
Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.
Request for Free Sample…
Neoantigen Peptide Manufacturing Market Research Report 2023 - InsightAce Analyt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during…
Latest Comprehensive Neoantigen Cancer Vaccine Market CAGR of 76% during forecas …
Neoantigen Cancer Vaccine Market Information:
Straits Research has recently added a new report to its vast depository titled Neoantigen Cancer Vaccine Market. The report studies vital factors about the Neoantigen Cancer Vaccine Market that are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and many…
